June 26, 2025 · Form 4 insider transaction
MALCOLM JAN bought 630 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 32 days after the transaction.
Shares received upon vesting of restricted stock units on June 26, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.